Back

IRE1-dependent GOLIM4 expression controls protein secretion to modulate glioblastoma cell adhesion and migration

Bakambamba, K.; Nivet, M.; Sauzay, C.; Martin, S.; Lafont, E.; Negroni, L.; Chevet, E.; Avril, T.

2024-10-25 cancer biology
10.1101/2024.10.22.619629 bioRxiv
Show abstract

One of the main glioblastoma (GB) features is the diffuse migration of the tumor cells within the surrounding brain parenchyma, rendering almost impossible the complete tumor resection and irradiation, leading to inexorable lethal relapse of the disease. In the past years, we demonstrated that IRE1 (hereafter IRE1), one of the Endoplasmic Reticulum (ER) stress sensors, plays a key role in GB biology by impacting on immune infiltration, angiogenesis and tumor cell migration/invasion, all these features being linked to an alteration of protein secretion. In the present study, we investigated if and how IRE1 could regulate the functionality of the secretory machinery in GB cells and identified GOLIM4, a Golgi-associated molecule whose expression is regulated downstream of IRE1 through the transcription of XBP1s. Interestingly, GOLIM4 silencing led to decreased surface expression of multiple molecules including MHC class I molecules, growth factor receptors (PDGFRA and IL13RA2) and proteins involved in cell-cell adhesion (CD44, CD54, NCAM1), adhesion to matrix (ITGB1) or cell migration (CD90) without alteration of their encoding transcripts expression levels. Moreover, GOLIM4 silencing phenotypically affected GB cell-cell adhesion and cell migration in multiple models. Overall, we have described a novel IRE1/XBP1s/GOLIM4 operon that controls the secretion of specific proteins and impacts the tumor aggressiveness. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=100 SRC="FIGDIR/small/619629v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@511636org.highwire.dtl.DTLVardef@18971f6org.highwire.dtl.DTLVardef@98ff81org.highwire.dtl.DTLVardef@ae7189_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 15 journals account for 50% of the predicted probability mass.

1
Neoplasia
22 papers in training set
Top 0.1%
8.4%
2
Cells
232 papers in training set
Top 0.1%
7.0%
3
International Journal of Molecular Sciences
453 papers in training set
Top 1%
5.0%
4
Scientific Reports
3102 papers in training set
Top 30%
4.1%
5
iScience
1063 papers in training set
Top 4%
3.8%
6
Cell Reports
1338 papers in training set
Top 14%
3.7%
7
Cell Death & Disease
126 papers in training set
Top 0.3%
3.7%
8
Computational and Structural Biotechnology Journal
216 papers in training set
Top 2%
2.8%
9
Cancer Letters
32 papers in training set
Top 0.1%
2.1%
10
Cell Communication and Signaling
35 papers in training set
Top 0.3%
1.9%
11
PLOS ONE
4510 papers in training set
Top 50%
1.9%
12
Molecular Oncology
50 papers in training set
Top 0.3%
1.8%
13
Neuro-Oncology Advances
24 papers in training set
Top 0.3%
1.7%
14
Frontiers in Oncology
95 papers in training set
Top 2%
1.7%
15
Biomolecules
95 papers in training set
Top 0.4%
1.7%
50% of probability mass above
16
Frontiers in Molecular Biosciences
100 papers in training set
Top 2%
1.5%
17
Biomedicines
66 papers in training set
Top 1%
1.4%
18
Computers in Biology and Medicine
120 papers in training set
Top 3%
1.3%
19
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 6%
1.3%
20
International Journal of Biological Macromolecules
65 papers in training set
Top 3%
1.0%
21
Theranostics
33 papers in training set
Top 1.0%
1.0%
22
Neuro-Oncology
30 papers in training set
Top 0.6%
1.0%
23
Life Sciences
25 papers in training set
Top 0.9%
1.0%
24
Glia
74 papers in training set
Top 0.4%
0.9%
25
Cancers
200 papers in training set
Top 4%
0.9%
26
Clinical Epigenetics
53 papers in training set
Top 0.8%
0.9%
27
Acta Neuropathologica Communications
81 papers in training set
Top 0.9%
0.9%
28
Environmental Research
46 papers in training set
Top 1%
0.9%
29
Life Science Alliance
263 papers in training set
Top 1%
0.9%
30
Heliyon
146 papers in training set
Top 5%
0.8%